Dr. Jain is a National Eye Institute/NIH funded clinician-scientist and is the Director of the Dry Eye and ocular GVHD clinic. He also directs the Translational Biology Laboratory in the Department. His clinical and translational research work has led to numerous publications in professional journals as well as development of drugs that are in phase I/II clinical trials. He is a member of the Editorial Board of leading Journals in Ophthalmology such as Investigative Ophthalmology and Visual Science, Ocular Surface and Scientific Reports. He has been named one of America’s Best Doctors® since 2007 and has received the American Academy of Ophthalmology’s Achievement Award. He has received several awards and recognition, including Departmental Faculty of the Year from UIC and Physician-Scientist Award from Research to Prevent Blindness. He serves as primary mentor on NEI/NIH grants for clinician-scientist career development of junior faculty. Dr. Jain is the founder and chief scientific officer at Advaite LLC, a startup that this focused on the development of innovative pharmaceuticals and healthcare solutions. After receiving his medical degree, Dr. Jain joined the Wilmer Ophthalmological Institute at The Johns Hopkins University as a pre-residency fellow and completed his residency training in Ophthalmology at the Harkness Eye Institute at Columbia University, New York, followed by subspecialty fellowship in Corneal Diseases at the Massachusetts Eye & Ear Infirmary/Harvard Medical School. Dr. Jain joined the Illinois Eye and Ear Infirmary in 2006. He is board certified in ophthalmology.
MD—University of Delhi, India Research Fellowship in Cornea and External Diseases—Wilmer Eye Institute, Johns Hopkins University, Baltimore Residency—Harkness Eye Institute, Columbia University, New York Clinical Fellowship in Cornea—Massachusetts Eye and Ear Infirmary, Harvard Medical School Scholars for Teaching Excellence Faculty Fellowship, University of Illinois at Chicago
Selected Honors and Awards
Faculty of the Year Award, College of Medicine, University of Illinois at Chicago, 2015 Research to Prevent Blindness Physician Scientist Award, 2014 Chicago Super Doctors, 2013 Best Doctors in America, 2007 – 2014 American Academy of Ophthalmology Achievement Award, 2002
Shaheen BS, Bakir M, Jain S. Corneal nerves in health and disease. Surv Ophthalmol. 2014 Jan 22. pii: S0039-6257(13)00208-7. doi: 10.1016/j.survophthal.2013.09.002. [Epub ahead of print] PubMed PMID: 24461367.
Tibrewal S, Sarkar J, Jassim SH, Gandhi S, Sonawane S, Chaudhary S, Byun YS, Ivanir Y, Hallak J, Horner JH, Newcomb M, Jain S. Tear fluid extracellular DNA: diagnostic and therapeutic implications in dry eye disease. Invest Ophthalmol Vis Sci. 2013 Dec 11;54(13):8051-61. doi: 10.1167/iovs.13-12844. PubMed PMID: 24255046; PubMed Central PMCID: PMC3860379.
Ogawa Y, Kim SK, Dana R, Clayton J, Jain S, Rosenblatt MI, Perez VL, Shikari H, Riemens A, Tsubota K. International Chronic Ocular Graft-vs-Host-Disease (GVHD) Consensus Group: Proposed Diagnostic Criteria for Chronic GVHD (Part I). Sci Rep. 2013 Dec 5;3:3419. doi: 10.1038/srep03419. PubMed PMID: 24305504; PubMed Central PMCID: PMC3851919.
Sarkar J, Chaudhary S, Jassim SH, Ozturk O, Chamon W, Ganesh B, Tibrewal S, Gandhi S, Byun YS, Hallak J, Mahmud DL, Mahmud N, Rondelli D, Jain S. CD11b+GR1+ myeloid cells secrete NGF and promote trigeminal ganglion neurite growth: implications for corneal nerve regeneration. Invest Ophthalmol Vis Sci. 2013 Sep 3;54(9):5920-36. doi: 10.1167/iovs.13-12237. PubMed PMID: 23942970; PubMed Central PMCID: PMC3762328.
Tu EY, Jain S. Topical linezolid 0.2% for the treatment of vancomycin-resistant or vancomycin-intolerant gram-positive bacterial keratitis. Am J Ophthalmol. 2013 Jun;155(6):1095-1098.e1. doi: 10.1016/j.ajo.2013.01.010. Epub 2013 Feb 26. PubMed PMID: 23453280.
Hallak JA, Jassim S, Khanolkar V, Jain S. Symptom burden of patients with dry eye disease: a four domain analysis. PLoS One. 2013 Dec 13;8(12):e82805. doi: 10.1371/journal.pone.0082805. eCollection 2013. PubMed PMID: 24349365; PubMed Central PMCID: PMC3862676.
Sonawane S, Khanolkar V, Namavari A, Chaudhary S, Gandhi S, Tibrewal S, Jassim SH, Shaheen B, Hallak J, Horner JH, Newcomb M, Sarkar J, Jain S. Ocular surface extracellular DNA and nuclease activity imbalance: a new paradigm for inflammation in dry eye disease. Invest Ophthalmol Vis Sci. 2012 Dec 17;53(13):8253-63. doi: 10.1167/iovs.12-10430. PubMed PMID: 23169882; PubMed Central PMCID: PMC3525138.
Chaudhary S, Namavari A, Yco L, Chang JH, Sonawane S, Khanolkar V, Sarkar J, Jain S. Neurotrophins and nerve regeneration-associated genes are expressed in the cornea after lamellar flap surgery. Cornea. 2012 Dec;31(12):1460-7. doi: 10.1097/ICO.0b013e318247b60e. PubMed PMID: 22673847; PubMed Central PMCID: PMC3612527.
Namavari A, Chaudhary S, Ozturk O, Chang JH, Yco L, Sonawane S, Katam N, Khanolkar V, Hallak J, Sarkar J, Jain S. Semaphorin 7a links nerve regeneration and inflammation in the cornea. Invest Ophthalmol Vis Sci. 2012 Jul 9;53(8):4575-85. doi: 10.1167/iovs.12-9760. PubMed PMID: 22700709; PubMed Central PMCID: PMC3394693.
Jain S, De la Cruz J, Kang E, Kojima T, Chang JH, Kim JY. Expression of phosphorylated heat shock protein 27 during corneal epithelial wound healing. Cornea. 2012 Jul;31(7):820-7. doi: 10.1097/ICO.0b013e31823f7685. PubMed PMID: 22262220; PubMed Central PMCID: PMC3649853.
Sarkar J, Chaudhary S, Namavari A, Ozturk O, Chang JH, Yco L, Sonawane S, Khanolkar V, Hallak J, Jain S. Corneal neurotoxicity due to topical benzalkonium chloride. Invest Ophthalmol Vis Sci. 2012 Apr 6;53(4):1792-802. doi: 10.1167/iovs.11-8775. PubMed PMID: 22410563.
Namavari A, Chaudhary S, Chang JH, Yco L, Sonawane S, Khanolkar V, Yue BY, Sarkar J, Jain S. Cyclosporine immunomodulation retards regeneration of surgically transected corneal nerves. Invest Ophthalmol Vis Sci. 2012 Feb 13;53(2):732-40. doi: 10.1167/iovs.11-8445. Print 2012 Feb. PubMed PMID: 22205605; PubMed Central PMCID: PMC3317418.
Chang JH, Garg NK, Lunde E, Han KY, Jain S, Azar DT. Corneal neovascularization: an anti-VEGF therapy review. Surv Ophthalmol. 2012 Sep;57(5):415-29. doi: 10.1016/j.survophthal.2012.01.007. Review. PubMed PMID: 22898649; PubMed Central PMCID: PMC3709023.
Han KY, Fahd DC, Tshionyi M, Allemann N, Jain S, Chang JH, Azar DT. MT1-MMP modulates bFGF-induced VEGF-A expression in corneal fibroblasts. Protein Pept Lett. 2012 Dec;19(12):1334-9. PubMed PMID: 22670674; PubMed Central PMCID: PMC3653774.
Han KY, Azar DT, Sabri A, Lee H, Jain S, Lee BS, Chang JH. Characterization of the interaction between endostatin short peptide and VEGF receptor 3. Protein Pept Lett. 2012 Sep;19(9):969-74. PubMed PMID: 22512651; PubMed Central PMCID: PMC3646568.
Tshionyi M, Shay E, Lunde E, Lin A, Han KY, Jain S, Chang JH, Azar DT. Hemangiogenesis and lymphangiogenesis in corneal pathology. Cornea. 2012 Jan;31(1):74-80. doi: 10.1097/ICO.0b013e31821dd986. PubMed PMID: 22030600; PubMed Central PMCID: PMC3710690.
Categories: Ophthalmology, Ophthalmology Research Faculty